Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Diastolic Heart Failure: perception of the syndrome and scope of the problem. As a result of the recent publications of the CHARM-Preserved trial, the upcoming I-PRESERVE and other still ongoing clinical trials in patients with Heart Failure and Normal (or Preserved) Left Ventricular Ejection Fraction, numerous questions have arisen as for the conceptual rationale and pathophysiological basis of such trials. The present symposium is a synopsis of the most important remaining controversies. We gratefully acknowledge all authors for their contribution as summarized in this Introduction Paper.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.pcad.2006.08.003 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!